297 related articles for article (PubMed ID: 33796403)
21. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
Meja KK; Barnes PJ; Giembycz MA
Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541
[TBL] [Abstract][Full Text] [Related]
22. PGE2-EP4 signaling steers cDC2 maturation toward the induction of suppressive T-cell responses.
Cuenca-Escalona J; Flórez-Grau G; van den Dries K; Cambi A; de Vries IJM
Eur J Immunol; 2024 Mar; 54(3):e2350770. PubMed ID: 38088451
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of tumor-derived prostaglandin-e2 blocks the induction of myeloid-derived suppressor cells and recovers natural killer cell activity.
Mao Y; Sarhan D; Steven A; Seliger B; Kiessling R; Lundqvist A
Clin Cancer Res; 2014 Aug; 20(15):4096-106. PubMed ID: 24907113
[TBL] [Abstract][Full Text] [Related]
24. Prostaglandin E2 receptors of the EP2 and EP4 subtypes downregulate tumor necrosis factor alpha-induced intercellular adhesion molecule-1 expression in human gingival fibroblasts.
Noguchi K; Iwasaki K; Shitashige M; Ishikawa I
J Periodontal Res; 1999 Nov; 34(8):478-85. PubMed ID: 10697805
[TBL] [Abstract][Full Text] [Related]
25. Myeloid Cell Prostaglandin E2 Receptor EP4 Modulates Cytokine Production but Not Atherogenesis in a Mouse Model of Type 1 Diabetes.
Vallerie SN; Kramer F; Barnhart S; Kanter JE; Breyer RM; Andreasson KI; Bornfeldt KE
PLoS One; 2016; 11(6):e0158316. PubMed ID: 27351842
[TBL] [Abstract][Full Text] [Related]
26. Blocking EP4 down-regulates tumor metabolism and synergizes with anti-PD-1 therapy to activate natural killer cells in a lung adenocarcinoma model.
Tokumasu M; Nishida M; Kawaguchi T; Kudo I; Kotani T; Takeda K; Yoshida T; Udono H
Int Immunol; 2022 Jun; 34(6):293-302. PubMed ID: 35137101
[TBL] [Abstract][Full Text] [Related]
27. Prostaglandin E2-stimulated prostanoid EP4 receptors induce prolonged de novo prostaglandin E2 synthesis through biphasic phosphorylation of extracellular signal-regulated kinases mediated by activation of protein kinase A in HCA-7 human colon cancer cells.
Fujino H; Seira N; Kurata N; Araki Y; Nakamura H; Regan JW; Murayama T
Eur J Pharmacol; 2015 Dec; 768():149-59. PubMed ID: 26518053
[TBL] [Abstract][Full Text] [Related]
28. Reprogramming immunosuppressive myeloid cells facilitates immunotherapy for colorectal cancer.
Lu W; Yu W; He J; Liu W; Yang J; Lin X; Zhang Y; Wang X; Jiang W; Luo J; Zhang Q; Yang H; Peng S; Yi Z; Ren S; Chen J; Siwko S; Nussinov R; Cheng F; Zhang H; Liu M
EMBO Mol Med; 2021 Jan; 13(1):e12798. PubMed ID: 33283987
[TBL] [Abstract][Full Text] [Related]
29. Prostaglandin E2 receptors of the EP2 and EP4 subtypes regulate activation and differentiation of mouse B lymphocytes to IgE-secreting cells.
Fedyk ER; Phipps RP
Proc Natl Acad Sci U S A; 1996 Oct; 93(20):10978-83. PubMed ID: 8855294
[TBL] [Abstract][Full Text] [Related]
30. The COX-2-PGE2 Pathway Promotes Tumor Evasion in Colorectal Adenomas.
Wei J; Zhang J; Wang D; Cen B; Lang JD; DuBois RN
Cancer Prev Res (Phila); 2022 May; 15(5):285-296. PubMed ID: 35121582
[TBL] [Abstract][Full Text] [Related]
31. COX2/mPGES1/PGE2 pathway regulates PD-L1 expression in tumor-associated macrophages and myeloid-derived suppressor cells.
Prima V; Kaliberova LN; Kaliberov S; Curiel DT; Kusmartsev S
Proc Natl Acad Sci U S A; 2017 Jan; 114(5):1117-1122. PubMed ID: 28096371
[TBL] [Abstract][Full Text] [Related]
32. Salvia mitiorrhiza Bunge aqueous extract attenuates infiltration of tumor-associated macrophages and potentiates anti-PD-L1 immunotherapy in colorectal cancer through modulating Cox2/PGE2 cascade.
Song M; Qian C; Zhang T; Tang Y; Zhou Y; Wei Z; Wang A; Zhong C; Zhao Y; Lu Y
J Ethnopharmacol; 2023 Nov; 316():116735. PubMed ID: 37286115
[TBL] [Abstract][Full Text] [Related]
33. Prostaglandin E2 Inhibits NLRP3 Inflammasome Activation through EP4 Receptor and Intracellular Cyclic AMP in Human Macrophages.
Sokolowska M; Chen LY; Liu Y; Martinez-Anton A; Qi HY; Logun C; Alsaaty S; Park YH; Kastner DL; Chae JJ; Shelhamer JH
J Immunol; 2015 Jun; 194(11):5472-5487. PubMed ID: 25917098
[TBL] [Abstract][Full Text] [Related]
34. Direct growth-inhibitory effects of prostaglandin E2 in pancreatic cancer cells in vitro through an EP4/PKA-mediated mechanism.
Schmidt A; Sinnett-Smith J; Young S; Chang HH; Hines OJ; Dawson DW; Rozengurt E; Eibl G
Surgery; 2017 Jun; 161(6):1570-1578. PubMed ID: 28222855
[TBL] [Abstract][Full Text] [Related]
35. E prostanoid 2 (EP2)/EP4-mediated suppression of antigen-specific human T-cell responses by prostaglandin E2.
Okano M; Sugata Y; Fujiwara T; Matsumoto R; Nishibori M; Shimizu K; Maeda M; Kimura Y; Kariya S; Hattori H; Yokoyama M; Kino K; Nishizaki K
Immunology; 2006 Jul; 118(3):343-52. PubMed ID: 16827895
[TBL] [Abstract][Full Text] [Related]
36. PGE
Lacher SB; Dörr J; de Almeida GP; Hönninger J; Bayerl F; Hirschberger A; Pedde AM; Meiser P; Ramsauer L; Rudolph TJ; Spranger N; Morotti M; Grimm AJ; Jarosch S; Oner A; Gregor L; Lesch S; Michaelides S; Fertig L; Briukhovetska D; Majed L; Stock S; Busch DH; Buchholz VR; Knolle PA; Zehn D; Dangaj Laniti D; Kobold S; Böttcher JP
Nature; 2024 May; 629(8011):417-425. PubMed ID: 38658748
[TBL] [Abstract][Full Text] [Related]
37. EP4 as a Therapeutic Target for Aggressive Human Breast Cancer.
Majumder M; Nandi P; Omar A; Ugwuagbo KC; Lala PK
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29596308
[TBL] [Abstract][Full Text] [Related]
38. A prostaglandin E (PGE) receptor EP4 antagonist protects natural killer cells from PGE
Ma X; Holt D; Kundu N; Reader J; Goloubeva O; Take Y; Fulton AM
Oncoimmunology; 2013 Jan; 2(1):e22647. PubMed ID: 23482441
[TBL] [Abstract][Full Text] [Related]
39. Prostaglandin E2 promotes proliferation of skeletal muscle myoblasts via EP4 receptor activation.
Mo C; Zhao R; Vallejo J; Igwe O; Bonewald L; Wetmore L; Brotto M
Cell Cycle; 2015; 14(10):1507-16. PubMed ID: 25785867
[TBL] [Abstract][Full Text] [Related]
40. Induction of prostaglandin E2 synthesis and microsomal prostaglandin E synthase-1 expression in murine microglia by glioma-derived soluble factors. Laboratory investigation.
Nakano Y; Kuroda E; Kito T; Uematsu S; Akira S; Yokota A; Nishizawa S; Yamashita U
J Neurosurg; 2008 Feb; 108(2):311-9. PubMed ID: 18240928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
